Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aces, a Japan-based image recognition software developer incubated by University of Tokyo’s Matsuo Lab, has raised ¥320m ($3.1m) from consulting firm Industrial Growth Platform and Deep30, the AI-focused venture capital vehicle for the Matsuo Lab. It previously collected an undisclosed amount of seed financing from Deep30 in May 2019. Confluence Pharmaceuticals, a US-based neurological disorder drug developer exploiting Indiana University research, received $100,000 of bridge funding yesterday from Indiana University’s Philanthropic Venture Fund. Confluence is targeting symptoms such as impaired focus associated with neurodevelopment disorders such as autism. The company is preparing for phase 2 clinical trials, and plans to seek series B capital next year. IU Philanthropic Venture Fund previously invested $200,000 into Confluence Pharmaceuticals in late 2018, adding to $1.3m from a series A round closed two years previously with investors including Elevate Ventures’ 21st Century Research & Technology Fund. Transkriptorium, a Spain-based document transcription and indexing technology producer, has spun out of Polytechnic University of Valencia, La Vanguardia reported yesterday. The company will offer machine learning-driven statistical analysis to digitise handwritten documents. Sánchez Peiró and Enrique Vidal, two professors from Polytechnic University of Valencia’s Department of Information Systems and Computing, are the spinout’s scientific co-founders.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?